Mesa Laboratories, Inc. (MLAB) vs Procore Technologies, Inc. (PCOR)
The same free fields, in the same order, for both companies, so a figure on one line can be read straight across.
This page states measurements and nothing else. It does not rank the two companies, name one of them, or draw a conclusion from the figures.
Data as of Oct 27, 2026, for both companies.
The figures, field by field
A dash means the snapshot carries no figure for that company on that line. A line is dropped only when neither company has it, so a dash beside a figure is a fact about coverage, not about either company.
| MLAB | PCOR | |
|---|---|---|
| Sector | Technology | Technology |
| Industry | Scientific & Technical Instruments | Software - Application |
| Size band | SMALL | MID |
| Listing | Nasdaq GS | NYSE |
| Country | United States | United States |
| Theme | life-science-tools | saas |
| Price and returns | ||
| Last close | $129.87 | $62.77 |
| Return · 1 week | +5.32% | +8.21% |
| Return · 1 month | −2.35% | +27.95% |
| Return · 3 months | +28.46% | +28.52% |
| Return · year to date | +63.78% | −10.38% |
| Return · 1 year | +69.52% | −15.69% |
| Distance from the 52-week highThe last close measured against the highest close of the past 52 weeks. | −10.03% | −23.74% |
| 52-week high | $144.35 | $82.32 |
| 52-week low | $69.51 | $38.03 |
| Size and turnover | ||
| Market value · USDConverted to US dollars, so two companies listed in different currencies sit under one heading. | $719.96M | $9.54B |
| Turnover · median day, USDThe median value traded in a session over the past 50 sessions. | $16.58M | $174.55M |
| Employees | 717 | 4,421 |
| Valuation | ||
| Price to earnings · trailing | 151.36× | n/a (negative earnings) |
| Price to earnings · forward | 12.53× | 23.67× |
| Price to sales | 2.88× | 6.00× |
| Price to book | 3.81× | 6.68× |
| Enterprise value to EBITDA | 18.69× | 118.71× |
| Enterprise value to revenue | 3.40× | 5.44× |
| Earnings per share · trailing | 0.85 | -0.26 |
| Profitability | ||
| Gross margin | 64.21% | 79.96% |
| Operating margin | 11.69% | 2.34% |
| Profit margin | 1.92% | −2.73% |
| Return on equity | 2.66% | −3.12% |
| Return on assets | 3.29% | −1.51% |
| Growth | ||
| Revenue growth | +1.00% | +15.80% |
| Earnings growth | −42.40% | — |
| Balance sheet and payout | ||
| Debt / equity (%) | 85.48 | 5.28 |
| Current ratio | 1.79 | 1.17 |
| Dividend yield | 0.50% | 0.00% |
| Payout ratio | 75.29% | — |
| Trend and volatility | ||
| RSI · 14 | 53.45 | 71.62 |
| ADX · 14 | 21.54 | 28.67 |
| 50-day average | $127.18 | $56.64 |
| 200-day average | $103.25 | $53.58 |
| Average true range · share of priceAverage true range over 14 sessions, stated as a share of the last close, so it can be read across two share prices. | 3.31% | 3.47% |
The full MLAB analysis
Everything this table leaves out for Mesa Laboratories, Inc.: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the MLAB argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full MLAB analysisThe full PCOR analysis
Everything this table leaves out for Procore Technologies, Inc.: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the PCOR argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full PCOR analysis